BeyondSpring Inc. (BYSI)
Last updated: 2026-11-01 16:09:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
BeyondSpring Inc. (BYSI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalization of $26.47M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.42 to $2.44. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$26.47M | |
$0.50 | |
$48.49 | |
$0.42 | |
$0.52 | |
216.23K | |
876.64K | |
-- | |
$2.44 | |
$0.42 | |
-- | |
-- |
BeyondSpring Inc. (BYSI) Latest Closing Stock Price
BeyondSpring Inc. (BYSI) last closed at $0.52 as of 2026-10-30 23:42:00, unchanged from the previous close of $0.52.
During the latest regular trading session, BYSI traded between $0.42 and $48.49, with a volume of 216.23K shares. The closing price was near the lower end and near the lower end of its 52-week range.
BeyondSpring Inc. (BYSI) 7-Day Stock Price Change
Over the past seven days, BeyondSpring Inc. (BYSI) moved from $0.45 to $0.65, representing a gain of 44.91% ($0.20).
The stock traded between $0.42 and $0.68 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 66.20 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
BYSI 52-Week Price Position
Position in Range: 11.1%
BYSI is currently trading at $0.65, placing it 11.1% of the way from its 52-week low of $0.42 to its 52-week high of $2.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is BeyondSpring Inc. (BYSI)?
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
BeyondSpring Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 44 |
| Exchange | NASDAQ |
| Company Website |
How to Buy BeyondSpring Inc. (BYSI) Stock on MEXC
Eligible investors can buy real shares of BeyondSpring Inc. (BYSI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is BeyondSpring Inc. (BYSI) stock price today?
2.Is BYSI stock going up or down today?
3.What is BYSI pre-market price?
4.What is BYSI after-hours price?
5.Is BYSI stock trading now?
6.Where does BYSI sit relative to its 52-week high and low?
7.What sector is BeyondSpring Inc. in?
8.What is BeyondSpring Inc.'s market capitalization and where is it listed?
9.How is BYSI valued in terms of P/E ratio and EPS?
10.Does BeyondSpring Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BYSI Stock Calculator
Estimate the value between BYSI shares and USD.
BYSI Shares to USD
1.00 BYSI shares = 0.645 USD
Calculations are estimates based on the latest available price and are for reference only.


